Rippled skin, fasciitis, and joint contractures

Journal of the American Academy of Dermatology

Volumn 59, Issue 6, 2008, Pages 1070-1074

  Patel, Asha R ^a   Avila, Daniele ^a   Malech, Harry L ^b   Pavletic, Steven Z ^a   Yao, Larry ^c   Cowen, Edward W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; METHOTREXATE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CUTANEOUS CHRONIC GRAFT VERSUS HOST DISEASE; FASCIITIS; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; JOINT CONTRACTURE; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE;

ADULT; CONTRACTURE; FASCIITIS; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHOTOPHERESIS; SCLEROSIS; SKIN DISEASES;

EID: 55949085288     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.08.023     Document Type: Article

References (34)

1. Fraser C.J., and Scott Baker K. The management and outcome of chronic graft-versus-host disease. Br J Haematol 138 (2007) 131-145
2. Hymes S.R., Turner M.L., Champlin R.E., and Couriel D.R. Cutaneous manifestations of chronic graft-versus-host disease. Biol Blood Marrow Transplant 12 (2006) 1101-1113
3. Filipovich A.H., Weisdorf D., Pavletic S., Socie G., Wingard J.R., Lee S.J., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11 (2005) 945-956
4. van den Bergh V., Tricot G., Fonteyn G., Dom R., and Bulcke J. Diffuse fasciitis after bone marrow transplantation. Am J Med 83 (1987) 139-143
5. Janin A., Socie G., Devergie A., Aractingi S., Esperou H., Vérola O., et al. Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases. Ann Intern Med 120 (1994) 993-998
6. Carroll C.B., Hilton D.A., Hamon M., and Zajicek J.P. Muscle cramps and weakness secondary to graft versus host disease fasciitis. Eur J Neurol 12 (2005) 320-322
7. Dumford K., and Anderson J.C. CT and MRI findings in sclerodermatous chronic graft vs. host disease. Clin Imaging 25 (2001) 138-140
8. Clark J., Yao L., Turner M.L., and Cowen E.W. Magnetic resonance imaging for the diagnosis of subcutaneous involvement in patients with chronic graft-versus-host disease. J Am Acad Dermatol 58 Suppl 2 (2008) AB85
9. Peñas P.F., Jones-Caballero M., Aragüés M., Fernández-Herrera J., Fraga J., and García-Díez A. Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients. Arch Dermatol 138 (2002) 924-934
10. Chosidow O., Bagot M., Vernant J.P., Roujeau J.C., Cordonnier C., Kuentz M., et al. Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. J Am Acad Dermatol 26 (1992) 49-55
11. Skert C., Patriarca F., Sperotto A., Cerno M., Filì C., Zaja F., et al. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome. Haematologica 91 (2006) 258-261
12. Patel A.R., Pavletic S.Z., Turner M.L., and Cowen E.W. The isomorphic response in morphealike chronic graft-versus-host disease. Arch Dermatol 144 (2008) 1229-1231
13. Lee S.J., Vogelsang G., and Flowers M.E. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9 (2003) 215-233
14. Johnson M.L., and Farmer E.R. Graft-versus-host reactions in dermatology. J Am Acad Dermatol 38 (1998) 369-392
15. Sakoda Y., Hashimoto D., Asakura S., Takeuchi K., Harada M., Tanimoto M., et al. Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. Blood 109 (2007) 1756-1764
16. Ochs L.A., Blazar B.R., Roy J., Rest E.B., and Weisdorf D.J. Cytokine expression in human cutaneous chronic graft-versus-host disease. Bone Marrow Transplant 17 (1996) 1085-1092
17. Svegliati S., Olivieri A., Campelli N., Luchetti M., Poloni A., Trappolini S., et al. Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease. Blood 110 (2007) 237-241
18. White J.M., Creamer D., du Vivier A.W., Pagliuca A., Ho A.Y., Devereux S., et al. Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges. Br J Dermatol 156 (2007) 1032-1038
19. Breuckmann F., Gambichler T., Altmeyer P., and Kreuter A. UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review. BMC Dermatol 4 (2004) 11
20. Marshall S.R. Technology insight: ECP for the treatment of GvHD-can we offer selective immune control without generalized immunosuppression?. Nat Clin Pract Oncol 3 (2006) 302-314
21. Ratanatharathorn V., Ayash L., Reynolds C., Silver S., Reddy P., Becker M., et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant 9 (2003) 505-511
22. Canninga-van Dijk M.R., van der Straaten H.M., Fijnheer R., Sanders C.J., van den Tweel J.G., and Verdonck L.F. Anti-CD20 monoclonal antibody treatment in 6 patients with therapy refractory chronic graft-versus-host disease. Blood 104 (2004) 2603-2606
23. Cutler C., Miklos D., Kim H.T., Treister N., Woo S.B., Bienfang D., et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 108 (2006) 756-762
24. Kamble R., Oholendt M., and Carrum G. Rituximab responsive refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 12 (2006) 1201-1202
25. Okamoto M., Okano A., Akamatsu S., Ashihara E., Inaba T., Takenaka H., et al. Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease. Leukemia 20 (2006) 172-173
26. Carella A.M., Biasco S., Nati S., Congiu A., and Lerma E. Rituximab is effective for extensive steroid-refractory chronic graft-vs. host-disease. Leuk Lymphoma 48 (2007) 623-624
27. Zaja F., Bacigalupo A., Patriarca F., Stanzani M., Van Lint M.T., Fili C., et al. Treatment of refractory chronic GVHD with rituximab: a GITMO study. Bone Marrow Transplant 40 (2007) 273-277
28. Mohty M., Marchetti N., El-Cheikh J., Faucher C., Fürst S., and Blaise D. Rituximab as salvage therapy for refractory chronic GVHD. Bone Marrow Transplant (2008 Feb 18) [Epub ahead of print]
29. Gilman A.L., Chan K.W., Mogul A., Morris C., Goldman F.D., Boyer M., et al. Hydroxychloroquine for the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 6 (2000) 327-334
30. Sokos D.R., Berger M., and Lazarus H.M. Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 8 (2002) 117-130
31. Vogelsang G.B., and Arai S. Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings. Bone Marrow Transplant 27 (2001) 1255-1262
32. Jacobsohn D.A., Chen A.R., Zahurak M., Piantadosi S., Anders V., Bolaños-Meade J., et al. Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. J Clin Oncol 25 (2007) 4255-4261
33. Browne P.V., Weisdorf D.J., DeFor T., Miller W.J., Davies S.M., Filipovich A., et al. Response to thalidomide therapy in refractory chronic graft-versus-host disease. Bone Marrow Transplant 26 (2000) 865-869
34. Beredjiklian P.K., Drummond D.S., Dormans J.P., Davidson R.S., Brock G.T., and August C. Orthopaedic manifestations of chronic graft-versus-host disease. J Pediatr Orthop 18 (1998) 572-575